Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports binding selectivity to certain protein targets, enhancing drug efficacy. The compound's fluorinated aromatic and cyclopropane motifs contribute to metabolic stability and improved pharmacokinetic profiles in final drug formulations. It is also employed in research settings for exploring new bioactive molecules with central nervous system activity.